Literature DB >> 25474146

Morphological disease progression of combined pulmonary fibrosis and emphysema: comparison with emphysema alone and pulmonary fibrosis alone.

Shin Matsuoka1, Tsuneo Yamashiro, Shoichiro Matsushita, Atsuko Fujikawa, Akiyuki Kotoku, Kunihiro Yagihashi, Yasuyuki Kurihara, Yasuo Nakajima.   

Abstract

OBJECTIVES: The purpose of this study was to evaluate the differences in 5-year morphological changes among the patients with combined pulmonary fibrosis and emphysema (CPFE), emphysema alone, and fibrosis alone using quantitative computed tomography evaluation.
METHODS: This study involved 42 patients with CPFE, 45 patients with emphysema alone, and 35 patients with fibrosis alone who underwent computed tomography scans twice (initial and 5 years after the initial scan). The extent of emphysematous lesions was obtained by calculating the percentage of low attenuation area (%LAA) lower than -950 Hounsfield units. Fibrotic lesion was defined as a high attenuation area (HAA) using thresholds with pixels between 0 and -700 Hounsfield units, and the extent of fibrosis was obtained by calculating the mean percentage of HAA (%HAA). For the quantitative evaluation of the total area of emphysematous change and fibrosis, the percentage of destructed lung area (%DA) was obtained by summing %LAA and %HAA. The 5-year changes of %LAA, %HAA, and %DA were calculated. Differences were evaluated by 1-way analysis of variance, which was followed by the Tukey-Kramer test.
RESULTS: The mean change of %LAA was significantly higher in CPFE (7.4% ± 3.8%) than in emphysema alone (P < 0.05). The mean change of %DA was significantly higher in CPFE (12.9% ± 5.8%) than in emphysema alone (4.9% ± 2.8%) and fibrosis alone (7.1% ± 5.7%).
CONCLUSIONS: Morphological disease progression in CPFE differed from that in emphysema alone or fibrosis alone. In particular, the increase in emphysematous low-attenuation lesions was significantly higher in CPFE.

Entities:  

Mesh:

Year:  2015        PMID: 25474146     DOI: 10.1097/RCT.0000000000000184

Source DB:  PubMed          Journal:  J Comput Assist Tomogr        ISSN: 0363-8715            Impact factor:   1.826


  9 in total

1.  High attenuation areas on chest computed tomography in community-dwelling adults: the MESA study.

Authors:  Anna J Podolanczuk; Elizabeth C Oelsner; R Graham Barr; Eric A Hoffman; Hilary F Armstrong; John H M Austin; Robert C Basner; Matthew N Bartels; Jason D Christie; Paul L Enright; Bernadette R Gochuico; Karen Hinckley Stukovsky; Joel D Kaufman; P Hrudaya Nath; John D Newell; Scott M Palmer; Dan Rabinowitz; Ganesh Raghu; Jessica L Sell; Jered Sieren; Sushil K Sonavane; Russell P Tracy; Jubal R Watts; Kayleen Williams; Steven M Kawut; David J Lederer
Journal:  Eur Respir J       Date:  2016-07-28       Impact factor: 16.671

Review 2.  Smoking-related lung abnormalities on computed tomography images: comparison with pathological findings.

Authors:  Tae Iwasawa; Tamiko Takemura; Takashi Ogura
Journal:  Jpn J Radiol       Date:  2017-12-15       Impact factor: 2.374

3.  Quantitative evaluation of interstitial pneumonia using 3D-curved high-resolution CT imaging parallel to the chest wall: A pilot study.

Authors:  Hiroyasu Umakoshi; Shingo Iwano; Tsutomu Inoue; Yuanzhong Li; Shinji Naganawa
Journal:  PLoS One       Date:  2017-09-28       Impact factor: 3.240

4.  Objective quantitative multidetector computed tomography assessments in patients with combined pulmonary fibrosis with emphysema: Relationship with pulmonary function and clinical events.

Authors:  Masaki Suzuki; Naoko Kawata; Mitsuhiro Abe; Hajime Yokota; Rie Anazawa; Yukiko Matsuura; Jun Ikari; Shin Matsuoka; Kenji Tsushima; Koichiro Tatsumi
Journal:  PLoS One       Date:  2020-09-17       Impact factor: 3.240

5.  Quantitative CT analysis in patients with pulmonary emphysema: is lung function influenced by concomitant unspecific pulmonary fibrosis?

Authors:  Felix W Feldhaus; Dorothea Cornelia Theilig; Ralf-Harto Hubner; Jan-Martin Kuhnigk; Konrad Neumann; Felix Doellinger
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2019-07-17

Review 6.  Chronic Obstructive Pulmonary Disease Combined with Interstitial Lung Disease.

Authors:  Joon Young Choi; Jin Woo Song; Chin Kook Rhee
Journal:  Tuberc Respir Dis (Seoul)       Date:  2022-01-27

7.  Serum Levels of Surfactant Proteins in Patients with Combined Pulmonary Fibrosis and Emphysema (CPFE).

Authors:  Andriana I Papaioannou; Konstantinos Kostikas; Effrosyni D Manali; Georgia Papadaki; Aneza Roussou; Aris Spathis; Argyro Mazioti; Ioannis Tomos; Ilias Papanikolaou; Stelios Loukides; Kyriakos Chainis; Petros Karakitsos; Matthias Griese; Spyros Papiris
Journal:  PLoS One       Date:  2016-06-23       Impact factor: 3.240

8.  Differentiating Smoking-Related Interstitial Fibrosis (SRIF) from Usual Interstitial Pneumonia (UIP) with Emphysema Using CT Features Based on Pathologically Proven Cases.

Authors:  Kum Ju Chae; Gong Yong Jin; Hyun Nyeong Jung; Keun Sang Kwon; Hyemi Choi; Yong Chul Lee; Myoung Ja Chung; Ho Sung Park
Journal:  PLoS One       Date:  2016-09-09       Impact factor: 3.240

9.  Differentiating combined pulmonary fibrosis and emphysema from pure emphysema: utility of late gadolinium-enhanced MRI.

Authors:  Hannah Fleming; Simon M Clifford; Aoife Haughey; Roisin MacDermott; Niall McVeigh; Gerard M Healy; Lisa Lavelle; Suhny Abbara; David J Murphy; Aurelie Fabre; Edward McKone; Cormac McCarthy; Marcus Butler; Peter Doran; David A Lynch; Michael P Keane; Jonathan D Dodd
Journal:  Eur Radiol Exp       Date:  2020-11-03
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.